LSD1-IN-32
LSD1-IN-32 (compound 11e) is a potent LSD1 inhibitor with an IC50 value of 0.99 µM. LSD1-IN-32 inhibits RANKL-induced osteoclastogenesis, bone resorption and F-actin belt formation. LSD1-IN-32 has the potential for the research of osteoporosis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C36H56N2O3Si2
- 分子量:621.01
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
Histone Methyltransferase アイソフォーム固有の製品をすべて表示
More
生物活性
IC50: 0.99 µM (LSD1)[1]
LSD1-IN-32 (compound 11e) (1.25, 2.5, 5 µM) increases the methylation level during osteoclastogenesis in a dose-dependent manner[1].
LSD1-IN-32 (0.25, 0.5, 1, 2, 4 µM) inhibits RANKL-induced osteoclastogenesis, bone resorption and F-actin belt formation[1].
LSD1-IN-32 (2 µM; 0, 1, 2, 4 days) reduces the relative mRNA expression levels induced by RANKL of those genes of Acp5, Nfatc1, Oscar, Dc-stamp, Atp6v0d2, and Ctsk[1].
LSD1-IN-32 (0.5, 1, 2, 4 µM) inhibits the expressions of p-LSD1, p-IκB and p-NFκB in RANKL-induced osteoclastogenesis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:osteoclasts
-
Concentration:2 µM
-
Incubation Time:0, 1, 2, 4 days
-
Result:Reduced the relative mRNA expression levels of those genes (Acp5, Nfatc1, Oscar, Dc-stamp, Atp6v0d2, and Ctsk) induced by RANKL.
-
Cell Line:osteoclasts
-
Concentration:0.5, 1, 2, 4 µM
-
Incubation Time:
-
Result:Dose dependently inhibited the expressions of p-LSD1, p-IκB and p-NFκB in RANKL-induced osteoclastogenesis.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:7-week-old C57BL/6 female mice (OVX (ovariectomy)-induced osteoporosis)[1]
-
Dosage:5, 10 mg/kg
-
Administration:I.p.; daily for four weeks
-
Result:Significantly reduced the loss of the bone mass, reduced OVX-induced osteoclastic bone loss.
化学情報
-
分子量 621.01
-
分子式 C36H56N2O3Si2
-
SMILES
O=C(N1CCC(CN[C@H]2[C@H](C3=CC=CC=C3)C2)CC1)/C=C/C4=CC=C(O[Si](C)(C(C)(C)C)C)C(O[Si](C)(C(C)(C)C)C)=C4
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
LSD1-IN-32 関連分類
HY-161869 関連分類
Powered by Bioz